Trends in Exclusive Non-Cigarette Tobacco Smoking in England: A Population Survey 2013–2023

Nicotine & Tobacco Research, Journal Year: 2024, Volume and Issue: 27(2), P. 342 - 350

Published: March 5, 2024

The UK Government intends to implement a "smokefree generation" policy prohibiting the sale of all tobacco products people born after 2008. National surveys provide comprehensive data on cigarette smoking, but little is known about patterns non-cigarette smoking across key population groups. Using from nationally representative cross-sectional survey adults in England, collected monthly between September 2013 and 2023 (n = 196 721), we estimated time trends exclusive (eg, cigar/pipe/shisha) prevalence, overall by age, gender, occupational social grade, region, ethnicity, vaping status. Interviews were conducted face-to-face until March 2020 via telephone thereafter. From 2023, there was non-linear increase prevalence (from 0.36% 1.68%; ratio 4.72 [95% CI 3.43-6.48]). Prevalence relatively stable up February (at an average 0.46%), then increased sharply at start COVID-19 pandemic same as methods changed), 0.90% (0.82%-0.99%) 2020. This followed steadier rise, peaking 1.97% May 2022, before falling slightly 1.68% 2023. In 2022/2023, 1 10 smokers (10.8% [9.64%-12.0%]) exclusively used tobacco. rise observed subgroups most pronounced among younger reaching 3.21% 18-year-olds vs. 1.09% 65-year-olds). consistently higher men current vapers. Although use combustible remains rare it has recent years, particularly ages. As approximately 772 800 adult England; around five times more than decade earlier. proportion England who do not cigarettes smoke other substantially with young people. inclusion under proposed therefore likely be important for achieving greatest reduction youth uptake would ensure are unable legally buy that similarly harmful health.

Language: Английский

---

Using prospective mixed methods to investigate the effect of the COVID‐19 pandemic on cannabis demand

Journal of the Experimental Analysis of Behavior, Journal Year: 2025, Volume and Issue: unknown

Published: Feb. 25, 2025

Following the COVID-19 pandemic, it is vital to understand how major global stressors influence substance use, including cannabis-related outcomes. The Marijuana Purchase Task assesses hypothetical cannabis demand (i.e., relative reinforcing value) and can detect contextual alterations. This study paired prospective assessment with qualitative inquiry explore impacted use behavior. Individuals previously enrolled in a laboratory administration opted remote follow-up survey (n = 41, 46% female). Participants were categorized as those who did or not increase based on self-reported changes flower provided explanations regarding pandemic-related influences General linear models repeated measures examined mean differences by occasion before/during COVID-19), group did/did use), their interaction. Those increased exhibited significantly higher during pandemic; similar across time revealing Group × Time Thematic analysis contextualized quantitative findings, explaining external that affect (e.g., cost, access, environment). differentially demand, prepandemic affecting trajectories. Contextual availability, free time, income) facilitate escalation of under conditions extreme stress.

Language: Английский

---

Chronic Disease Symptoms Self-Managed by Cannabis During the COVID-19 Pandemic: Results from the COVID-19 Cannabis Health Study

Cannabis and Cannabinoid Research, Journal Year: 2025, Volume and Issue: unknown

Published: Feb. 26, 2025

Background: The COVID-19 pandemic has impacted billions of people worldwide, particularly those with chronic health conditions, and been associated increases in substance use, including cannabis. purpose this study was to estimate the prevalence cannabis use for symptom management conditions during pandemic. Methods: Cannabis Health Study is an ongoing among adults ≥18 who self-report use. Analyses included 1,466 responses received between March 21, 2020, 23, 2022, from participants self-reported a condition. We examined comorbidities, symptoms managed pandemic, fear regarding diagnosis transmission using Questionnaire. Descriptive statistics, Chi-squared, T-tests were conducted. Results stratified by reported manage condition (medicinal user, n = 1,333) did not (non-medicinal 133). Results: Most (90.9%, total sample (mean age: 47.1 years [standard deviations {SD} 15.0]) condition, which 46.1% (n 615) having medical card/recommendation, 4.6% recommendations professionals. There significant differences age, gender, race/ethnicity, education medicinal status. Comorbidities prevalent consumers mental health-related (66.1%), pain (58.5%), cardiometabolic-related (30.5%), immune-related (21.9%), respiratory-related (20.8%). most self-managed sleep (69.2%), noncancer (49.7%), acute (46.5%), headaches/migraines (39.0%), muscle spasms (33.6%), nausea/vomiting (30.6%), appetite stimulant (29.9%). no statistical testing, diagnosis, transmission, or isolation due nonmedicinal sample. Conclusions: perceived therapeutic benefit evident high reasons despite recommendation their provider. Research necessary understand prospective impact self-management disease, especially within context COVID-19.

Language: Английский

---

Sleep, psychological symptoms, and cannabis use before, during, and after COVID-19 “stay-at-home” orders: a structural equation modeling approach

Journal of Cannabis Research, Journal Year: 2025, Volume and Issue: 7(1)

Published: March 24, 2025

Abstract Background Given the frequent use of cannabis for sleep and mental health symptoms, we aimed to prospectively examine reciprocal relationship between sleep, health, from before, during, 1 year after implementation COVID-19 stay-at-home orders. Methods Five hundred thirty-four young adults (21–34 years old) Oregon Washington States who previously completed a survey on their prior orders (T0), were followed up initial in place approximately two months (T1), one later (T2), reassess use. Sleep measures included presence trouble [yes/no], weekday weekend duration. The Cannabis Use Disorders Identification Test Revised (CUDIT-R) was used assess past-six-month follow surveys additionally measured symptoms other behaviors. We applied cross-lagged panel models association at all three time points. Multivariate parallel latent change score associations changes use, behavioral factors T1 T2. Results For models, reporting T0 associated (β = 0.18, p < 0.05) with higher CUDIT-R scores T1, however this did not hold had positive 0.35, two-wave model, indicated that T2 positively depression ( r 0.37, anxiety 0.40, across period. No significant correlation found trouble. Conclusions Our findings suggest an inconsistent bidirectional link Only trouble, predicted measures. These lend support holistic approach designing implementing public during global pandemic.

Language: Английский

---

Changes in cannabis attitudes and perceptions in the five years following recreational legalization in Canada: Findings from an observational cohort study of community adults

International Journal of Drug Policy, Journal Year: 2025, Volume and Issue: 140, P. 104782 - 104782

Published: April 21, 2025

Social acceptability and perceived risks/benefits are key attitudinal factors that influence substance use, a major concern about cannabis legalization is an increase in more favourable attitudes ultimately leading to greater misuse. This study investigated perceptions of over the 5 years following Canada, first G7 nation have legalized nationally, longitudinal observational cohort community adults. Participants (60 % female, median age = 29, 48% reporting use pre-legalization) were non-clinical adults from general who assessed up 11 times September 2018 October 2023 (mean waves 9.9). Overall temporal changes whether moderated by pre-legalization status examined. Significant increases time present for social any recreational (OR [95% CI]: 1.06 [1.05, 1.07]) trying (1.02 [1.01, 1.03]), while medical decreased (0.95 [0.94, 0.96]). Meanwhile, regular was as riskier (0.97 [0.96, 0.98]) addiction potential (0.94 [0.93, 0.95]) time. Perceived health-related benefits significantly less likely be endorsed time, there significant risks, including exacerbating stress, anxiety, depression; existing conditions; disrupting sleep. Moderator analyses found participants not using showed steeper towards occasional steep endorsement cannabis-related risks. Shifting post-legalization Canada paralleled risks decreases benefits. Continued surveillance warranted inform impacts largest national legal jurisdiction well other jurisdictions considering regulatory reform.

Language: Английский

---

Telehealth tDCS to Reduce Cannabis Use: A Pilot RCT in Multiple Sclerosis as a Framework for Generalized Use

Drug and Alcohol Dependence, Journal Year: 2025, Volume and Issue: 272, P. 112706 - 112706

Published: May 9, 2025

Language: Английский

---

Cannabis use & food insecurity risk among U.S. adults with & without children

American Journal of Preventive Medicine, Journal Year: 2025, Volume and Issue: unknown, P. 107740 - 107740

Published: June 1, 2025

Language: Английский

---

Trends in cannabis use in New Jersey: Effects of COVID‐19 and cannabis legalization

Journal of the American College of Emergency Physicians Open, Journal Year: 2024, Volume and Issue: 5(3)

Published: June 1, 2024

Abstract Objectives With the legalization of cannabis in New Jersey on April 21, 2022, including licensing dispensaries, concerns have arisen about potential adverse events related to use. Here, we explore temporal trends and risk factors for cannabis‐related harm both adult pediatric visits at a tertiary care academic institution. Methods We performed retrospective chart review trend analysis via electronic health record from May 1, 2019 October 31, covering 2 years before, 6 months after, Jersey. The charts identified were analyzed root causes events, changes frequency specific unsafe practices since tracked. Results found that ED‐related significantly increased during COVID‐19 pandemic remained higher than pre‐pandemic levels remainder study periods, without significant change upon legalization. Pediatric rates ED did not vary period. vast majority children aged 0–12 accidental exposures—often household member's edibles—whereas most older stemmed intentional Conclusion This project highlights unintended consequences wider access Notably, use even before its legalization, presumably response attendant mental effects. Rates disorder highlight other concurrent psychiatric disorders are important topics clinicians lawmakers consider.

Language: Английский

---

Impact of the COVID-19 pandemic on cannabis cultivation and use in 18 countries

International Journal of Drug Policy, Journal Year: 2024, Volume and Issue: unknown, P. 104652 - 104652

Published: Nov. 1, 2024

Language: Английский

---

Medical Cannabis Availability and Mental Health: Evidence From New York’s Medical Cannabis Program

Published: May 1, 2024

Evidence on cannabis legalization's effects mental health remains scarce, despite both rapid increases in use and an ongoing crisis the United States.We granular geographic data to estimate medical dispensary availability's selfreported New York state from 2011 through 2021 using a two-stage differencein-differences approach minimize bias introduced staggered opening of dispensaries.Our findings rule out that availability had negative for adult population overall.We also find reduced past-month self-reported poor days by nearly 10%-3.37 percentage points-among adults 65 above.These results suggest access has positive impacts older populations, likely pain relief.

Language: Английский

---